Allianz Asset Management’s Immunovant IMVT Stock Holding History

Allianz Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$320K	Hold	12,900	–	–	﹤0.01%	1900
2025 Q4	$328K	Buy	+12,900	New	+$288K	﹤0.01%	1884
2024 Q4	–	Sell	-18,837	Closed	-$537K	–	2268
2024 Q3	$537K	Sell	18,837 -11,341	-38%	-$334K	﹤0.01%	1837
2024 Q2	$797K	Hold	30,178	–	–	﹤0.01%	1666
2024 Q1	$975K	Buy	30,178 +18,278	+154%	+$667K	﹤0.01%	1430
2023 Q4	$501K	Hold	11,900	–	–	﹤0.01%	1856
2023 Q3	$457K	Buy	+11,900	New	+$269K	﹤0.01%	1954
2021 Q2	–	Sell	-13,620	Closed	-$218K	–	2433
2021 Q1	$218K	Sell	13,620 -8,700	-39%	-$229K	﹤0.01%	2109
2020 Q4	$1.03M	Buy	+22,320	New	+$1.03M	﹤0.01%	1471

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Allianz Asset Management's IMVT Position: Q1 2026 in Review

Allianz Asset Management held its Immunovant (IMVT) position steady in Q1 2026 at 12,900 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #1900.

Allianz Asset Management first reported a position in IMVT in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.03M in Q4 2020. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

Allianz Asset Management held 12,900 shares of Immunovant worth $320K as of Q1 2026.
Allianz Asset Management left its Immunovant share count unchanged in Q1 2026.
Immunovant made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1900 holding.
Allianz Asset Management first reported a position in Immunovant in Q4 2020 and has held it in 9 quarters since.
Allianz Asset Management's Immunovant position peaked at $1.03M in Q4 2020.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.